The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Haloperidol 5mg/ml Solution for Injection

Mercury Pharmaceuticals (Ireland) LtdPA0073/101/001

Main Information

Trade NameHaloperidol 5mg/ml Solution for Injection
Active SubstancesHaloperidol
Dosage FormSolution for injection
Licence HolderMercury Pharmaceuticals (Ireland) Ltd
Licence NumberPA0073/101/001

Group Information

ATC CodeN05AD Butyrophenone derivatives
N05AD01 haloperidol


License statusAuthorised
Licence Issued12/10/1988
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back